Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor

Details for Australian Patent Application No. 2008239659 (hide)

Owner Millennium Pharmaceuticals, Inc.

Inventors Hollenbach, Stanley J.; Sinha, Uma; Andre, Patrick

Agent Spruson & Ferguson

Pub. Number AU-A-2008239659

PCT Pub. Number WO2008/127682

Priority 60/911,852 13.04.07 US

Filing date 11 April 2008

Wipo publication date 23 October 2008

International Classifications

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

5 November 2009 PCT application entered the National Phase

  PCT publication WO2008/127682 Priority application(s): WO2008/127682

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008239668-Combination therapies comprising quinoxaline inhibitors of PI3K-alpha for use in the treatment of cancer

2008239658-Inverse-vector method for smoothing dips and azimuths